[1]
Haitham Alhosni, Aisha Bojazyah, and Mohamed Bohlala, “HDAC Inhibitors (Vorinostat) As A Potential Therapy for Metastatic Breast Cancer”, Alq J Med App Sci, vol. 5, no. 1, pp. 6–12, Nov. 2021.